Strategic Communications & Meetings
Sample Programs
Omar specializes in developing strategic and competitive communication solutions for topics in ophthalmology, diabetes, cancer, the central nervous system, dermatology, and infectious disease.
With an emphasis on accurate research and empowering communications, Omar Consulting Group digs deep to clarify technical and scientific concepts and create messages for a broad range of audiences including potential investors, key opinion leaders, scientific editors, project managers, physicians, nurses, and patients.
View Sample ProgramSynopsis
AOPT:
Omar Consulting helped to arrange sessions at the meeting of the Association for Ocular Pharmacology and Therapeutics. This is an intimate single-track, and highly interactive conference held once every 2 years.
Disruptive Technologies: Ophthalmic Tools and Methods that Have Changed the Ways We See the Eye
(Moderators: Cheryl Rowe-Rendleman and Randolph Glickman)
Audacious Goals Initiative: Status and Impact
(Steven Becker, PhD, Program Coordinator, National Eye Institute, NIH)
Photoacoustic Imaging and Sensing: A New Way to See the Eye
(Randolph Glickman, PhD, Senderoff Professor of Vision Research/McCoy Professor of Ophthalmology, School of Medicine, University of Texas Health Science Center, San Antonio)
A Platform to Take on the Entire Progressive Retinal Degeneration Disease Continuum
(Francois Binette, Senior Vice President, Global Head of Product Development, Biotime)
Early stage detection of Glaucoma by monitoring nanostructure and function of RGC layer using Multifractal OCT
(Subrata Batabyal, PhD, Senior Technical Officer, Nanoscope Technologies LLC )
Preclinical Evaluation of ADVM-022, a Novel Gene Therapy Approach to Treating Wet Age-Related Macular Degeneration
(Claire M. Gelfman, PhD, Executive Director Pharmaceutical Development, Adverum Biotechnologies, Inc)
Panel Discussion
(moderated by Cheryl Rowe-Rendleman, PhD, Consultant at Omar Consulting Group)
ISER:
Omar Consulting helped to arrange sessions at the meeting of the International Society for Eye Research. This meeting is provides a unique international platform for discussion of contemporary issues that affect patients and the broader eye research community.
Session: Ocular Pharmacology, Therapeutics & Drug Delivery
Personalized medicine and other innovations
Cheryl L. Rowe-Rendleman, United States
Carol Toris, Cleveland, OH, United States Personalized Medicine: Equal Access for All?
Eydie Miller-Ellis, Pennsylvania, United States Age and Ethnic Differences in the Eye Show the Need for Personalized Medicine
Vinit Mahajan, CA United States Proteomic Identification of Vitreous Biomarkers for Retinal Degeneration
Cheryl L. Rowe-Rendleman, NJ. United States Practicalities of Individualized Medicine—Is it Realistic?
Source: http://www.iserbiennialmeeting2018.org/program/program-overview.html
Regulations, Generics, and Disruptive Technologies in Ophthalmology: What Every Scientist Needs to Know
Cheryl L. Rowe-Rendleman and Randolph D. Glickman
Published Online: 8 Apr 2021
Biosimilars and Generic Medications in Ophthalmology
Alon Harris, Barbara Wirostko, Cheryl L. Rowe-Rendleman, Brent Siesky, Alice C. Verticchio Vercellin, Thomas A. Ciulla, Scott Wentz, Neil P. Finnen, Ingrida Januleviciene, Miriam Kolko
Coming Soon Kugler Publishing: 2022
Transcription services
Omar Consultants will come to your advisory board meeting or conference and transcribe important talks for further development into white papers and research reports.